COVID-19 Vaccine Delivery Partnership, (CoVDP) has handed over vehicles, motorbikes and computers worth of US$ 2.8M to support Sierra Leone Vaccination efforts.

INFUSE is an innovation scaling hub that matches investors with innovators and entrepreneurs to help scale up new ways to improve vaccination coverage in lower-income countries

Gavi’s first multisectoral private sector partnership to include nutrition as part of holistic approach to disease prevention.

Board underlines commitment to end backsliding in routine immunisation, catching up coverage and reaching zero-dose children as the Vaccine Alliance’s core priorities for the remainder of the current 2020–2025 strategic period.

3 November 2022 – Following the declaration of an Ebola outbreak in Uganda on 20 September 2022, the outbreak has now spread to seven districts (Kasanda, Kyegegwa, Bunyangabu and Kagadi districts beyond the original epicenter in Mubende district…

Gavi publishes plan of action to support the development of sustainable vaccine manufacturing in Africa.

Following an alarming global rise in measles cases and outbreaks, lower Income countries are accelerating efforts with support from Gavi, the Vaccine Alliance.

Gavi and Moderna agree to cancel remaining volumes under existing COVAX supply agreement.

In a move to protect adolescent girls from cervical cancer, the Government of Sierra Leone today introduced the Human Papilloma Virus (HPV) vaccine to the routine immunisation schedule and launched the start of a campaign to reach 153,991 girls…

Routine immunisation coverage fell for a second consecutive year in 2021 across 57 Gavi-supported countries, although preliminary data shows signs of improvement in early 2022.

The VIS Steering Committee will be convened to provide expert advice across multiple perspectives and deliberations and will provide technical input into the development of Gavi Secretariat’s recommendations to the Programme and Policy Committee…

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and…